Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-22-001132
Filing Date
2022-05-16
Accepted
2022-05-16 10:53:31
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING sgbi-20220331.htm   iXBRL 10-Q 728654
2 CERTIFICATION sgbi_ex31z1.htm EX-31.1 7187
3 CERTIFICATION sgbi_ex31z2.htm EX-31.2 7751
4 CERTIFICATION sgbi_ex32z1.htm EX-32.1 4324
  Complete submission text file 0001096906-22-001132.txt   2891973

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgbi-20220331_cal.xml EX-101.CAL 28274
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgbi-20220331_def.xml EX-101.DEF 59569
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgbi-20220331_lab.xml EX-101.LAB 146804
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgbi-20220331_pre.xml EX-101.PRE 131332
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgbi-20220331.xsd EX-101.SCH 43943
45 EXTRACTED XBRL INSTANCE DOCUMENT sgbi-20220331_htm.xml XML 393601
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 22926490
SIC: 2834 Pharmaceutical Preparations